Crizotinib (Xalkori) for Non-Small Cell Lung Cancer

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2012年 / 54卷 / 1383期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [11] Overcoming crizotinib resistance in ALK-rearranged non-small cell lung cancer
    Qi, Xiaolong
    Ma, Wang
    Li, Sen
    Zhou, Caicun
    LUNG CANCER, 2014, 85 (02) : 335 - 336
  • [12] Clinical Implications of the Pharmacokinetics of Crizotinib in Populations of Patients with Non-Small Cell Lung Cancer
    Wang, Erjian
    Nickens, Dana J.
    Bello, Akintunde
    Khosravan, Reza
    Amantea, Michael
    Wilner, Keith D.
    Parivar, Kourosh
    Tan, Weiwei
    CLINICAL CANCER RESEARCH, 2016, 22 (23) : 5722 - 5728
  • [13] The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer
    Friboulet, Luc
    Li, Nanxin
    Katayama, Ryohei
    Lee, Christian C.
    Gainor, Justin F.
    Crystal, Adam S.
    Michellys, Pierre-Yves
    Awad, Mark M.
    Yanagitani, Noriko
    Kim, Sungjoon
    Pferdekamper, AnneMarie C.
    Li, Jie
    Kasibhatla, Shailaja
    Sun, Frank
    Sun, Xiuying
    Hua, Su
    McNamara, Peter
    Mahmood, Sidra
    Lockerman, Elizabeth L.
    Fujita, Naoya
    Nishio, Makoto
    Harris, Jennifer L.
    Shaw, Alice T.
    Engelman, Jeffrey A.
    CANCER DISCOVERY, 2014, 4 (06) : 662 - 673
  • [14] IDENTIFYING ADDITIONAL MOLECULAR TARGETS FOR CRIZOTINIB IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Rogers, T. M.
    Russell, P.
    Wright, G.
    Wainer, Z.
    Fox, S. B.
    Solomon, B.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S181 - S181
  • [15] Relevance of sun safety in patients commencing crizotinib for non-small cell lung cancer
    Heynemann, Sarah
    Mitchell, Paul
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (02) : E332 - E333
  • [16] Crizotinib for ROS1-rearranged non-small cell lung cancer patients
    Domblides, Charlotte
    Antoine, Martine
    Lavole, Armelle
    Cadranel, Jacques
    Wislez, Marie
    BULLETIN DU CANCER, 2017, 104 (04) : 303 - 310
  • [17] Crizotinib withdrawalDisease flare in a patient with non-small cell lung cancer: case report
    Reactions Weekly, 2013, 1477 (1) : 14 - 14
  • [18] Crizotinib attenuates cancer metastasis by inhibiting TGFβ signaling in non-small cell lung cancer cells
    Soonbum Park
    Eun A Cho
    Jung Nyeo Chun
    Da Young Lee
    Sanghoon Lee
    Mi Yeon Kim
    Sang Mun Bae
    Su In Jo
    So Hee Lee
    Hyun Ho Park
    Tae Min Kim
    Insuk So
    Sang-Yeob Kim
    Ju-Hong Jeon
    Experimental & Molecular Medicine, 2022, 54 : 1225 - 1235
  • [19] Crizotinib attenuates cancer metastasis by inhibiting TGFβ signaling in non-small cell lung cancer cells
    Park, Soonbum
    Cho, Eun A.
    Chun, Jung Nyeo
    Lee, Da Young
    Lee, Sanghoon
    Kim, Mi Yeon
    Bae, Sang Mun
    Jo, Su In
    Lee, So Hee
    Park, Hyun Ho
    Kim, Tae Min
    So, Insuk
    Kim, Sang-Yeob
    Jeon, Ju-Hong
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2022, 54 (08): : 1225 - 1235
  • [20] Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer
    Peng Liu
    Liwei Zhao
    Jonathan Pol
    Sarah Levesque
    Adriana Petrazzuolo
    Christina Pfirschke
    Camilla Engblom
    Steffen Rickelt
    Takahiro Yamazaki
    Kristina Iribarren
    Laura Senovilla
    Lucillia Bezu
    Erika Vacchelli
    Valentina Sica
    Andréa Melis
    Tiffany Martin
    Lin Xia
    Heng Yang
    Qingqing Li
    Jinfeng Chen
    Sylvère Durand
    Fanny Aprahamian
    Deborah Lefevre
    Sophie Broutin
    Angelo Paci
    Amaury Bongers
    Veronique Minard-Colin
    Eric Tartour
    Laurence Zitvogel
    Lionel Apetoh
    Yuting Ma
    Mikael J. Pittet
    Oliver Kepp
    Guido Kroemer
    Nature Communications, 10
12345